The largest database of trusted experimental protocols

Hif 1α antibody

Manufactured by Merck Group

The HIF-1α antibody is a laboratory reagent used for the detection and quantification of the HIF-1α protein. HIF-1α is a transcription factor that plays a crucial role in the cellular response to hypoxia. The antibody can be used in various research applications, such as Western blotting, immunohistochemistry, and ELISA, to study the expression and regulation of HIF-1α.

Automatically generated - may contain errors

5 protocols using hif 1α antibody

1

HIV-1 Tat Regulation of HIF-1α and BACE1-AS

Check if the same lab product or an alternative is used in the 5 most similar protocols
HPAs were seeded in a 100-mm petri dish at the density of 2 × 106 cells and incubated overnight at 37°C in a humidified, 5% CO2 incubator. Cells were serum starved at approximately 70%–80% confluency, followed by exposure to HIV-1 Tat. Control and HIV-1 Tat–treated HPAs were harvested and RIP assay was performed with EZ-Magna RIP kit (Millipore Sigma, St. Louis, MO, 17–701) as per the manufacturer’s protocol. HIF-1α antibody (Millipore Sigma, St. Louis, MO, MAB5382) was used to perform the immunoprecipitation of RNA-binding protein/RNA complexes. Isolated RNAs from the input and enrichment fractions were used to either prepare cDNA using the verso cDNA synthesis kit (Thermo Fischer Scientific, Waltham, MA, AB 1453A) or for RNA sequencing. The reverse transcribed RNA was analyzed with the 7500 Fast Real-Time PCR System (Applied Biosystems, Grand Island, NY) with the TaqMan Universal PCR Master Mix (Applied Biosystems, Grand Island, NY 4304437, Thermo Fisher Scientific, Waltham, MA,), and BACE1-AS primers were used for qRT-PCR.
+ Open protocol
+ Expand
2

HIF-1α Regulation of BACE1 Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
Similar to the RIP assay, HPAs were seeded in a 100-mm petri dish at the density of approximately 2 × 106 cells and incubated overnight at 37°C in a humidified, 5% CO2 incubator. Cells were serum starved at approximately 70%–80% confluency, followed by HIV-1 Tat exposure. Control and HIV-1 Tat–treated HPAs were harvested, and ChIP assay was performed using the EZ-Magna ChIP A/G ChIP kit (Millipore Sigma, St. Louis, MO, 17–10086) as per the manufacturer’s protocol. HIF-1α antibody (Millipore Sigma, St. Louis, MO, MAB5382) was used to perform the immunoprecipitation of DNA-binding protein/DNA complexes. Isolated DNAs were analyzed using the 7500 Fast Real-Time PCR System (Applied Biosystems, Grand Island, NY) with the RT2 SYBR Green Fluor qPCR Mastermix (Qiagen, Hilden, Germany, 330510) or TaqMan Universal PCR Master Mix (Applied Biosystems, 4304437, Thermo Fisher Scientific, Waltham, MA,) for the BACE1 promoter. PCR products were subjected to agarose gel electrophoresis to confirm the binding of HIF-1α to the promoter of BACE1.
+ Open protocol
+ Expand
3

Visualizing Angiogenesis Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs and MCF-7 cells were grown on coverslips and treated with AECHL-1 in combination with VEGF, TNF-α or Deferoxamine. Cells grown till 70 % confluence were fixed with 3.7 % paraformaldehyde for 5 min, followed by permeabilization and blocking in 0.2 % Triton X100 and 5 % milk, respectively. Cells were washed three times with 1x PBS and incubated with primary antibody (HIF-1α, WAVE-2, IQGAP-1) and their respective Alexafluor-conjugated secondary antibodies. Nuclei were labeled using DAPI. The conditions for incubations, concentration of primary and the secondary labeled antibodies were standardized. F-actin was visualized using phalloidin (Molecular Probes) conjugated to either Alexafluor 488 or 647. The cells were viewed under CFLSM. Tumor vasculature and pericyte coverage were visualized in 8- and 30-μm-thick cryosections using CD-31 (1:50 BD Bioscience) and α-SMA (1:500, Sigma) antibodies, respectively, according to established protocols [29 (link), 30 (link)]. For studies involving immunohistochemistry, formalin-fixed paraffin-embedded (FFPE) sections of tumors were incubated with HIF-1α antibody (1:50, Sigma) and processed according to previously described protocol [31 (link)].
+ Open protocol
+ Expand
4

Chromatin Immunoprecipitation of HIF1α

Check if the same lab product or an alternative is used in the 5 most similar protocols
TPC1 cells were fixed in 1% formaldehyde for 10 min at 4°C. Cells were then sonicated to shear genomic DNA, followed by incubating overnight with 5 μg of Rb IgG or HIF1α antibody (Sigma, 1:2,000). The resulting complexes were precipitated using Fastflow G-Sepharose beads (GE Healthcare, Little Chalfont, United Kingdom), eluted, purified, and analyzed using PCR.
+ Open protocol
+ Expand
5

Signaling Pathways in Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Subconfluent LECs were treated with IGFBP7 in serum-free MCDB131 medium lacking ECGS in the presence or absence of VEGFA and/or IGFBP7. Cells were lysed with Chaps Cell Extract Buffer (Cell Signaling Technology). Samples (5–10 μg protein) were subjected to SDS-PAGE and transferred to a polyvinylidene membrane. The membranes were incubated with an anti-hypoxia-inducible factor-1α (HIF-1α) antibody (1:1000, Sigma), an anti-phospho-c-Raf antibody, an anti-phospho-MEK1/2 antibody, an anti-phospho-p42/44 mitogen-activated protein kinase (MAPK) (ERK1/2) antibody (1:1000) from a Phospho-ERK1/2 Pathway Kit, or an anti-MEK1/2 antibody (1:1000). After the detection of target proteins, the same membranes were reprobed with a mouse monoclonal anti-β-actin antibody (1:10,000; Sigma-Aldrich). Goat anti-rabbit or anti-mouse IgG (Vector Lab., Burlingame, CA, USA) (0.5 μg/ml) conjugated with horseradish peroxidase served as the secondary antibody for each analysis. Signals were detected
by enhanced chemiluminescence (PerkinElmer Life Sciences, Wellesley, MA, USA). All blotting experiments were repeated at least twice and representative data are shown.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!